Larimar Therapeutics Statistics
Total Valuation
LRMR has a market cap or net worth of $297.85 million. The enterprise value is $125.05 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LRMR has 85.59 million shares outstanding. The number of shares has increased by 20.08% in one year.
| Current Share Class | 85.59M |
| Shares Outstanding | 85.59M |
| Shares Change (YoY) | +20.08% |
| Shares Change (QoQ) | +22.33% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 33.19% |
| Float | 38.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.13 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.06 |
| Quick Ratio | 3.91 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.24% and return on invested capital (ROIC) is -50.33%.
| Return on Equity (ROE) | -78.24% |
| Return on Assets (ROA) | -42.99% |
| Return on Invested Capital (ROIC) | -50.33% |
| Return on Capital Employed (ROCE) | -98.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.03M |
| Employee Count | 65 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.60% in the last 52 weeks. The beta is 1.05, so LRMR's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -57.60% |
| 50-Day Moving Average | 4.14 |
| 200-Day Moving Average | 3.20 |
| Relative Strength Index (RSI) | 39.00 |
| Average Volume (20 Days) | 1,738,675 |
Short Selling Information
The latest short interest is 8.82 million, so 10.30% of the outstanding shares have been sold short.
| Short Interest | 8.82M |
| Short Previous Month | 8.94M |
| Short % of Shares Out | 10.30% |
| Short % of Float | 23.10% |
| Short Ratio (days to cover) | 1.96 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -139.77M |
| Pretax Income | -132.00M |
| Net Income | -132.00M |
| EBITDA | -139.43M |
| EBIT | -139.77M |
| Earnings Per Share (EPS) | -$1.95 |
Full Income Statement Balance Sheet
The company has $175.44 million in cash and $4.35 million in debt, giving a net cash position of $171.09 million or $2.00 per share.
| Cash & Cash Equivalents | 175.44M |
| Total Debt | 4.35M |
| Net Cash | 171.09M |
| Net Cash Per Share | $2.00 |
| Equity (Book Value) | 139.04M |
| Book Value Per Share | 1.62 |
| Working Capital | 138.11M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$96.49 million and capital expenditures -$270,000, giving a free cash flow of -$96.76 million.
| Operating Cash Flow | -96.49M |
| Capital Expenditures | -270,000 |
| Free Cash Flow | -96.76M |
| FCF Per Share | -$1.13 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LRMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.08% |
| Shareholder Yield | -20.08% |
| Earnings Yield | -44.57% |
| FCF Yield | -32.67% |
Analyst Forecast
The average price target for LRMR is $16.71, which is 380.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.71 |
| Price Target Difference | 380.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 2.65% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |